article thumbnail

Mogrify enters research collaboration with the MRC Laboratory of Molecular Biology

Drug Discovery Today

Exploratory research project aims to develop novel protein expression systems via cell reprogramming

article thumbnail

Multifaceted approach toward mapping out the anticancer properties of small molecules via in vitro evaluation on melanoma and nonmelanoma skin cancer cells, and in silico target fishing

Chemical Biology and Drug Design

To identify new lead compounds with potential anticancer properties for further optimization, in vitro assays combined with in-silico target fishing and docking have been used to identify and further map out the antiproliferative and potential mode of action of molecules from a small library of compounds previously prepared in our laboratory.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What Biology Can Learn from Physics

Codon

The Higgs boson was discovered at CERN, a sprawling particle physics laboratory that cost more than $10 billion to build. Predictive models for biology will span all scales, from individual proteins to the culture conditions in which cells grow. A predictive model for sequence-to-expression would raise the “hit” rates.

article thumbnail

What Biology Can Learn from Physics

Codon

The Higgs boson was discovered at CERN, a sprawling particle physics laboratory that cost more than $10 billion to build. Predictive models for biology will span all scales, from individual proteins to the culture conditions in which cells grow. A predictive model for sequence-to-expression would raise the “hit” rates.

article thumbnail

SARS-CoV-2: advancing the production of the ACE2 protein

Drug Target Review

Researchers from Columbia University and the US Department of Energy (DOE)’s Brookhaven National Laboratory have elucidated a method to produce large quantities of the receptor that the SARS-CoV-2 spike protein uses to bind to the surface of human cells.

article thumbnail

JS Bio and Etta Biotech Advancing Strategic Partnership

The Pharma Data

Etta Biotech”), to set up a high titer transient protein expression platform for high quality protein production using JS Bio’s transient transfection media. JS Bio becomes the exclusive cell culture supplier for Etta Biotech’s transient transfection high titer protein expression platform.

article thumbnail

Informed Design of Bioanalytical PCR Assay Testing Parameters

PPD

These treatments use a vector to introduce the desired nucleic acid code to replace or modify protein expression or use cells to alter/restore a specific cell type. In addition, laboratories should be positioned to have an agile response to rapidly adopt any new methods once regulatory guidance is published.